Please login to the form below
21
Revenue 2017Biogen Idec
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Biogen Idec's 2013 Oncology and CNS sales performance.
New report identifies key issues with NICE’s methods for evaluating Alzheimer’s drugs
While there are currently no licensed DMDTs in the UK, several are at varying stages of development and regulatory approval, including Eisai and Biogen’s lecanemab and Eli Lilly’s donanemab.
Alzheimer’s Research UK survey highlights dementia knowledge gaps
better.”. Last month, new data showed that a weekly subcutaneous dose of Biogen and Eisai’s Alzheimer’s disease drug Leqembi (lecanemab-irmb) removed 14% more amyloid plaque than the
Biogen/Eisai’s Alzheimer’s disease drug shows promise as subcutaneous formulation
Biogen and Eisai’s Alzheimer’s disease drug has shown promise as a subcutaneous (SC) formulation, according to new data presented by Eisai at this year’s Clinical Trials on
Biogen’s Actemra biosimilar approved by FDA to treat adult and paediatric arthritis
Biogen and Bio-Thera signed a global commercialisation agreement for Tofidence in 2021. ... In a statement, Biogen said it is “currently evaluating the potential launch timeline for Tofidence in the US”.
Innovate UK awards Sano Genetics £330,000 grant for ALS study
Participants will also have the opportunity to take part in new research studies as well as potentially take part in the testing of new therapies, including Biogen’s Qalsody (tofersen), the
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
